CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis
AIMS: Early phase cancer clinical trials have become more complicated and patients often misunderstand their nature and purpose. CONSENT (NCT04407676) is a randomised controlled trial testing whether enhanced informed consent for patient education can improve comprehension – since patients with glio...
Published in: | Neuro-Oncology |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Text |
Language: | English |
Published: |
Oxford University Press
2022
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525840/ https://doi.org/10.1093/neuonc/noac200.060 |
id |
ftpubmed:oai:pubmedcentral.nih.gov:9525840 |
---|---|
record_format |
openpolar |
spelling |
ftpubmed:oai:pubmedcentral.nih.gov:9525840 2023-11-05T03:42:36+01:00 CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis Pal, Abhijit Daly, Robert Mohamedkhan, Shybi Grochot, Rafael Stapleton, Sarah Yap, Christina Magkos, Dimitrios Baikady, Bindumalini Rao Minchom, Anna Banerji, Udai De Bono, Johann Karikios, Deme Boyle, Frances Lopez, Juanita 2022-10-01 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525840/ https://doi.org/10.1093/neuonc/noac200.060 en eng Oxford University Press http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525840/ http://dx.doi.org/10.1093/neuonc/noac200.060 © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com https://academic.oup.com/pages/standard-publication-reuse-rightsThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights) Neuro Oncol BNOS 2022 Abstracts: Poster Presentations Text 2022 ftpubmed https://doi.org/10.1093/neuonc/noac200.060 2023-10-08T00:43:09Z AIMS: Early phase cancer clinical trials have become more complicated and patients often misunderstand their nature and purpose. CONSENT (NCT04407676) is a randomised controlled trial testing whether enhanced informed consent for patient education can improve comprehension – since patients with glioblastoma multiforme (GBM) have a higher rate of baseline cognitive impairment, we studied this group separately. METHOD: GBM patients (from the ICE-CAP Phase 1 study - NCT03673787), underwent the schedule for the standard CONSENT arm - full length trial PIS, Quality of Informed Consent Questionnaire Parts A and B (QuIC-A and QuIC-B), experimental intervention (2 page study aid and 10 educational videos), and a repeat QuIC-A and QuIC-B. The primary endpoint for this subgroup was the difference in QuIC-A scores before and after the intervention using a paired t-test. RESULTS: 6 patients with GBM were recruited - 3 did not complete any study questionnaires. The three pre intervention QuIC-A scores were 70, 81, 88, with a mean of 75 (unit reference 76). The three pre intervention QuIC-B scores were 69, 62, 75 with a mean of 69 (unit reference is 91). Only one patient completed the post intervention questionnaire - their QuIC-A score moved from 88 to 100. CONCLUSION: This study demonstrates the significant difficulties in studying comprehension in patients with GBM considering early phase trials. There is a need for creative multi-modality solutions to provide information to GBM patients considering clinical trials, and novel tools to assess the effectiveness of these solutions. Text Ice cap PubMed Central (PMC) Neuro-Oncology 24 Supplement_4 iv14 iv14 |
institution |
Open Polar |
collection |
PubMed Central (PMC) |
op_collection_id |
ftpubmed |
language |
English |
topic |
BNOS 2022 Abstracts: Poster Presentations |
spellingShingle |
BNOS 2022 Abstracts: Poster Presentations Pal, Abhijit Daly, Robert Mohamedkhan, Shybi Grochot, Rafael Stapleton, Sarah Yap, Christina Magkos, Dimitrios Baikady, Bindumalini Rao Minchom, Anna Banerji, Udai De Bono, Johann Karikios, Deme Boyle, Frances Lopez, Juanita CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis |
topic_facet |
BNOS 2022 Abstracts: Poster Presentations |
description |
AIMS: Early phase cancer clinical trials have become more complicated and patients often misunderstand their nature and purpose. CONSENT (NCT04407676) is a randomised controlled trial testing whether enhanced informed consent for patient education can improve comprehension – since patients with glioblastoma multiforme (GBM) have a higher rate of baseline cognitive impairment, we studied this group separately. METHOD: GBM patients (from the ICE-CAP Phase 1 study - NCT03673787), underwent the schedule for the standard CONSENT arm - full length trial PIS, Quality of Informed Consent Questionnaire Parts A and B (QuIC-A and QuIC-B), experimental intervention (2 page study aid and 10 educational videos), and a repeat QuIC-A and QuIC-B. The primary endpoint for this subgroup was the difference in QuIC-A scores before and after the intervention using a paired t-test. RESULTS: 6 patients with GBM were recruited - 3 did not complete any study questionnaires. The three pre intervention QuIC-A scores were 70, 81, 88, with a mean of 75 (unit reference 76). The three pre intervention QuIC-B scores were 69, 62, 75 with a mean of 69 (unit reference is 91). Only one patient completed the post intervention questionnaire - their QuIC-A score moved from 88 to 100. CONCLUSION: This study demonstrates the significant difficulties in studying comprehension in patients with GBM considering early phase trials. There is a need for creative multi-modality solutions to provide information to GBM patients considering clinical trials, and novel tools to assess the effectiveness of these solutions. |
format |
Text |
author |
Pal, Abhijit Daly, Robert Mohamedkhan, Shybi Grochot, Rafael Stapleton, Sarah Yap, Christina Magkos, Dimitrios Baikady, Bindumalini Rao Minchom, Anna Banerji, Udai De Bono, Johann Karikios, Deme Boyle, Frances Lopez, Juanita |
author_facet |
Pal, Abhijit Daly, Robert Mohamedkhan, Shybi Grochot, Rafael Stapleton, Sarah Yap, Christina Magkos, Dimitrios Baikady, Bindumalini Rao Minchom, Anna Banerji, Udai De Bono, Johann Karikios, Deme Boyle, Frances Lopez, Juanita |
author_sort |
Pal, Abhijit |
title |
CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis |
title_short |
CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis |
title_full |
CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis |
title_fullStr |
CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis |
title_full_unstemmed |
CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis |
title_sort |
consent - a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials – gbm cohort (nonrandomised) analysis |
publisher |
Oxford University Press |
publishDate |
2022 |
url |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525840/ https://doi.org/10.1093/neuonc/noac200.060 |
genre |
Ice cap |
genre_facet |
Ice cap |
op_source |
Neuro Oncol |
op_relation |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525840/ http://dx.doi.org/10.1093/neuonc/noac200.060 |
op_rights |
© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com https://academic.oup.com/pages/standard-publication-reuse-rightsThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights) |
op_doi |
https://doi.org/10.1093/neuonc/noac200.060 |
container_title |
Neuro-Oncology |
container_volume |
24 |
container_issue |
Supplement_4 |
container_start_page |
iv14 |
op_container_end_page |
iv14 |
_version_ |
1781699863742775296 |